Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
Clinical trial NCT01340209 · COMPLETED
Trial details
- NCT number
- NCT01340209
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-04-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.